APA (7th ed.) Citation

Nagler, A., Labopin, M., Swoboda, R., Schroeder, T., Hamladji, R., Griskevicius, L., . . . Mohty, M. (2024). Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation, 59(7), . https://doi.org/10.1038/s41409-024-02284-5

Chicago Style (17th ed.) Citation

Nagler, Arnon, et al. "Post-transplant Cyclophosphamide, Calcineurin Inhibitor, and Mycophenolate Mofetil Compared to Anti-thymocyte Globulin, Calcineurin Inhibitor, and Methotrexate Combinations as Graft-versus-host Disease Prophylaxis Post Allogeneic Stem Cell Transplantation from Sibling and Unrelated Donors in Patients with Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation." Bone Marrow Transplantation 59, no. 7 (2024). https://doi.org/10.1038/s41409-024-02284-5.

MLA (9th ed.) Citation

Nagler, Arnon, et al. "Post-transplant Cyclophosphamide, Calcineurin Inhibitor, and Mycophenolate Mofetil Compared to Anti-thymocyte Globulin, Calcineurin Inhibitor, and Methotrexate Combinations as Graft-versus-host Disease Prophylaxis Post Allogeneic Stem Cell Transplantation from Sibling and Unrelated Donors in Patients with Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation." Bone Marrow Transplantation, vol. 59, no. 7, 2024, https://doi.org/10.1038/s41409-024-02284-5.